孕产妇肥胖和医疗保健经验:在产前和产后护理中的看法和挑战
Elizete Sampaio Araujo1, Claudia Galindo Novoa2, Lorenza Machado Teixeira3
1Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil.
Psychology, health & medicine
|January 8, 2026
概括
巴西肥胖妇女面临不一致的产前护理. 虽然有些人得到了尊重的照顾,但近一半的人经历了体重耻辱和信息不足,突出了改善医疗保健实践的需要.
科学领域:
- 产科和妇科 产科和妇科
- 公共卫生 公共卫生
- 卫生社会学 卫生社会学
背景情况:
- 肥胖妇女的产前护理面临着重大的医疗保健挑战.
- 经验往往不一致和不利,影响母亲的健康结果.
- 了解患者的看法对于改善护理质量至关重要.
研究的目的:
- 探索肥胖的孕妇和产后妇女对巴西医疗保健经验的看法.
- 确定影响该人口产前和产后护理质量的关键因素.
主要方法:
- 使用网图学方法进行的定性实地研究.
- 用"集体主题话语"技术分析了149名参与者的证词.
主要成果:
- 超过一半 (52.7%) 报告了积极的医疗互动,欣赏尊重和同情心.
- 很大一部分 (47.3%) 接受了不符合标准的护理,其标志是基于体重的耻辱和信息不足.
- 医疗保健经验不一致,揭示了服务质量的差异.
结论:
- 在产前护理中,迫切需要解决基于体重的耻辱.
- 整合反污名化方法和人性化的护理实践对于改善孕产妇保健至关重要.
- 加强信息提供和确保尊重待遇对于肥胖妇女至关重要.
相关概念视频
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165


